Kim Paul's Form 4 filing
Fulgent Genetics, Inc. (FLGT) · filed Nov 18, 2021
- Accession no.
- 0001209191-21-065642
- Filed
- Nov 18, 2021
- Trade date
- Nov 16-18, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $208.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kim PaulCIK 0001253820 | Officer (CFO and Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2021 | Common Stock | SSaleDisposed | −455 | $95.50F2 | −$43,452.5 | 133,540 | Direct | |
| Nov 16, 2021 | Common Stock | SSaleDisposed | −1,214 | $95.50F2 | −$115,937 | 132,326 | Direct | |
| Nov 18, 2021 | Common Stock | SSaleDisposed | −500 | $97.46F4 | −$48,730 | 131,826 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple transactions at prices ranging from $95.3400 to $95.6200, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 2 transactions in Table I.
- F4
The shares were sold in multiple transactions at prices ranging from $97.1000 to $97.9350, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
Referenced by the price of 1 transaction in Table I.